Microbiocenosis-regulating therapy of inflammatory pathology of the oropharynx

Close metadata

Inflammatory pathology of the oropharynx, which does not lose its relevance, is a problem that is of interest to doctors of various specialties. As one of the main causes of inflammatory diseases of the pharynx, the influence of microorganisms, primarily viruses, on the mucous membrane of the upper respiratory tract is indicated. The authors of the article emphasize the importance of preserving the indigenous microbiota, which provides a barrier function and prevents the adhesion and colonization of pathogenic microorganisms. In this regard, the most effective and safe is local microbiocenosis-regulatory therapy using lysozyme, a natural peptide that has antiseptic, anti-inflammatory and immunoregulatory effects. As such a drug, the authors recommend the combined drug Lorolizin, which can be used in the treatment of acute pharyngitis, acute tonsillitis, and adenoiditis.

Keywords:

inflammation

oropharynx

pharyngitis

tonsillitis

local therapy

microbiota

lysozyme

Authors:

Gurov A.V.

N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia;
Sverzhevsky Research Institute of Clinical Otorhinolaryngology

ORCID: 0000-0001-9811-8397

Yushkina M.A.

N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia;
Sverzhevsky Research Institute of Clinical Otorhinolaryngology

ORCID: 0000-0002-9823-1047

Muzhichkova A.V.

N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia;
Sverzhevsky Research Institute of Clinical Otorhinolaryngology

ORCID: 0000-0001-5940-9343

Received:

17.11.2021

Accepted:

07.12.2021

List of references:

Nikiforova GN, Volkova KB. New opportunities therapy of inflammatory diseases of the pharynx. Consilium Medicum. 2015;17(11): 103-107. (In Russ.).
Cazzola M, Anapurapu S, Page CP. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: A meta-analysis. Pulmonary Pharmacology and Therapeutics. 2012; 25(1):62-68. https://doi.org/10.1016/j.pupt.2011.11.002
Finley CR, Chan DS, Garrison S, Korownyk C, Kolber MR, Campbell S, Eurich DT, Lindblad AJ, Vandermeer B, Allan GM. What are the most common conditions in primary care? Systematic eview. Canadian Family Physician. 2018;64(11):832-840.
Ovchinnikov AYu, Miroshnichenko NA, Nikolaeva YuO. Sore throat. Recent trends in treatment. Vestnik otorinolaringologii. 2020;85(4):35-39. (In Russ.). https://doi.org/10.17116/otorino20208504135.
Svistushkin VM, Nikiforova GN, Zolotova AV, Stepanova VA. Using of topical bacterial lysates in modern clinical practice. Medical Council. 2021;6:49-56. (In Russ.). https://doi.org/10.21518/2079-701X-2021-6-49-56
Klein MR. Infections of the Oropharynx. Emergency Medicine Clinics of North America. 2019;37(1):69-80. https://doi.org/10.1016/j.emc.2018.09.002
Palchun VT, Luchikhin LA, Kryukov AI. Vospalitel’nye zabolevaniya glotki. M.: GEOTAR-Media; 2012. (In Russ.).
Palchun VT, Kryukov AI, Magomedov MM. Rukovodstvo po ochagovoj infektsii v otorinolaringologii. M.: GEOTAR-Media; 2015. (In Russ.).
Lange MJ, Lasiter JC, Misfeldt ML. Toll-like receptors in tonsillar epithelial cells. International Journal of Pediatric Otorhinolaryngology. 2009;73(4):613-621. https://doi.org/10.1016/j.ijporl.2008.12.013
Palchun VT, Kryukov AI, Gurov AV, Ermolaev AG. Palatine tonsils: physiology and pathology. Vestnik otorinolaringologii. 2019;84(6):11-16. (In Russ.). https://doi.org/10.17116/otorino20198406111
Lesmeister MJ, Bothwell MR, Misfeldt ML. Toll-like receptor expression in the human nasopharyngeal tonsil (adenoid) and palantine tonsils: A preliminary report. International Journal of Pediatric Otorhinolaryngology. 2006;70(6):987-992. https://doi.org/10.1016/j.ijporl.2005.10.009
Tonguc Altin K, Topcuoglu N, Duman G, Unsal M, Celik A, Selvi Kuvvetli S, Kasikci E, Sahin F, Kulekci G. Antibacterial effects of saliva substitutes containing lysozyme or lactoferrin against Streptococcus mutans. Archives of Oral Biology. 2021;129:105183. https://doi.org/10.1016/j.archoralbio.2021.105183
Tenovuo J, Lumikari M, Soukka T. Salivary lysozyme, lactoferrin and peroxidases: antibacterial effects on cariogenic bacteria and clinical applications in preventive dentistry. Proceedings of the Finnish Dental Society. 1991;87(2):197-208.
Tonguc-Altin K, Sandalli N, Duman G, Selvi-Kuvvetli S, Topcuoglu N, Kulekci G. Development of novel formulations containing Lysozyme and Lactoferrin and evaluation of antibacterial effects on Mutans Streptococci and Lactobacilli. Archives of Oral Biology. 2015;60(5):706-714. https://doi.org/10.1016/j.archoralbio.2015.02.004
Wang B, Timilsena YP, Blanch E, Adhikari B. Lactoferrin: Structure, function, denaturation and digestion. Critical Reviews in Food Science and Nutrition. 2019;59(4):580-596. https://doi.org/10.1080/10408398.2017.1381583
Yang Y, Palm NW. Immunoglobulin A and the microbiome. Current Opinion in Microbiology. 2020;56:89-96. https://doi.org/10.1016/j.mib.2020.08.003
Proctor DM, Relman DA. The Landscape Ecology and Microbiota of the Human Nose, Mouth, and Throat. Cell Host and Microbe. 2017;21(4):421-432. https://doi.org/10.1016/j.chom.2017.03.011
Li N, Ma WT, Pang M, Fan QL, Hua JL. The Commensal Microbiota and Viral Infection: A Comprehensive Review. Frontiers in Immunology. 2019;10:1551 https://doi.org/10.3389/fimmu.2019.01551
Mukherjee S, Mitra R, Maitra A, Gupta S, Kumaran S, Chakrabortty A, Majumder PP. Sebum and hydration levels in speciic regions of human face significantly predict the nature and diversity of facial skin microbiome. Scientific Reports. 2016;6:36062. https://doi.org/10.1038/srep36062
Simonova EV, Ponomareva OA. The role of normal microflora in maintaining human health. Sibirskij meditsinskij zhurnal. 2008;83(8):20-25. (In Russ.).
Nardone G, Compare D, Rocco A. A microbiota-centric view of diseases of the upper gastrointestinal tract. The Lancet. Gastroenterology and Hepatology. 2017;2(4):298-312. https://doi.org/10.1016/S2468-1253(16)30108-X
Nesbitt H, Burke C, Haghi M. Manipulation of the Upper Respiratory Microbiota to Reduce Incidence and Severity of Upper Respiratory Viral Infections: A Literature Review. Frontiers in Microbiology. 2021;12:713703. https://doi.org/10.3389/fmicb.2021.713703
Rosas-Salazar C, Shilts MH, Tovchigrechko A, Schobel S, Chappell JD, Larkin EK, Shankar J, Yooseph S, Nelson KE, Halpin RA, Moore ML, Anderson LJ, Peebles RS Jr, Das SR, Hartert TV. Differences in the nasopharyngeal microbiome during acute respiratory tract infection with human rhinovirus and Respiratory Syncytial Virus in infancy. The Journal of Infectious Diseases. 2016;214(12): 1924-1928. https://doi.org/10.1093/infdis/jiw456
Yeoh YK, Chan MH, Chen Z, Lam EWH, Wong PY, Ngai CM, Chan PKS, Hui M. The human oral cavity microbiota composition during acute tonsillitis: a cross-sectional survey. BMC Oral Health. 2019;19(1):275. https://doi.org/10.1186/s12903-019-0956-5
Yang Y, Zheng W, Cai QY, Shrubsole MJ, Pei Z, Brucker R, Steinwandel MD, Bordenstein SR, Li Z, Blot WJ, Shu XO, Long J. Cigarette smoking and oral microbiota in low-income and African-American populations. Journal of Epidemiology and Community Health. 2019;73(12):1108-1115. https://doi.org/10.1136/jech-2019-212474
Gurov AV, Yushkina MA. The peculiar features of the microbial paysage and the problems of antibacterial therapy of the inflammatory ENT diseases in the patients presenting with diabetes mellitus. Vestnik otorinolaringologii. 2018;83(1):59-61. (In Russ.). https://doi.org/10.17116/otorino201883159-61
Krukov AI, Gurov AV, Yushkina MA, Ogorodnikov DS. Immunological disorders in patients with purulent-inflammatory pathology of ENT organs in conditions of comorbidity with diabetes mellitus. Vestnik otorinolaringologii. 2019;84(6):22-27. (In Russ.). https://doi.org/10.17116/otorino20198406122
Cots JM, Alós JI, Bárcena M, Boleda X, Cañada JL, Gómez N, Mendoza A, Vilaseca I, Llor C. Recomendaciones para el manejo de la faringoamigdalitis aguda del adulto [Recommendations for management of acute pharyngitis in adults]. Enfermedades Infecciosas y Microbiologia Clinica. 2016;34(9):585-594. (In Spanish). https://doi.org/10.1016/j.eimc.2015.02.010
Shulman ST. Acute streptococcal pharyngitis in pediatric medicine: current issues in diagnosis and management. Paediatric Drugs. 2003;5(Suppl 1):13-23.
Sidell D, Shapiro NL. Acute tonsillitis. Infectious Disorders Drug Targets. 2012;12(4):271-276. https://doi.org/10.2174/187152612801319230
Windfuhr JP, Toepfner N, Steffen G, Waldfahrer F, Berner R. Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management. European Archives of Oto-Rhino-Laryngology. 2016;273(4):973-987. https://doi.org/10.1007/s00405-015-3872-6
Bathala S, Eccles R. A review on the mechanism of sore throat in tonsillitis. The Journal of Laryngology and Otology. 2013;127(3): 227-232. https://doi.org/10.1017/S0022215112003003
Fugl A, Andersen CL. Epstein-Barr virus and its association with disease — a review of relevance to general practice. BMC Family Practice. 2019;20(1):62. https://doi.org/10.1186/s12875-019-0954-3
Ruymbeke H, Schouten J, Sermon F. EBV: not your Everyday Benign Virus. Acta Gastro-Enterologica Belgica. 2020;83(3):485-487.
Wat PJ, Strickler JG, Myers JL, Nordstrom MR. Herpes simplex infection causing acute necrotizing tonsillitis. Mayo Clinic Proceedings. 1994;69(3):269-271. https://doi.org/10.1016/s0025-6196(12)61067-2
Krishnan PA. Fungal infections of the oral mucosa. Indian Journal of Dental Research. 2012;23(5):650-659. https://doi.org/10.4103/0970-9290.107384
Pankhurst CL. Candidiasis (oropharyngeal). BMJ Clinical Evidence. 2013;2013:1304.
Ahmad I, Mirza T, Qadeer K, Nazim U, Vaid FH. Vitamin B6: deficiency diseases and methods of analysis. Pakistan Journal of Pharmaceutical Sciences. 2013;26(5):1057-1069.
Karpova EP, Ardatskaya MD, Zakharova IN, Sugyan NG, Oborkin VYu. Biocenosis-saving therapy of acute inflammatory diseases of the oropharynx in children. Medical Council. 2017;19:168-173. (In Russ.).
Nikiforova GN, Svistushkin VM, Bidanova DB, Volkova KB. Efficiency of application of complex topical drugs in patients with inflammatory diseases of the pharynx. Medical Council. 2017;8:24-28. (In Russ.). https://doi.org/10.21518/2079-701X-2017-8-24-28

Close metadata